Overall, these results indicate that telmisartan treatment could regulate proliferation, cell cycle arrest, and apoptosis in A498, ACHN, Cak1, and Caki2 RCC cells via inhibition of JAK2. This evidence concerns the gene JAK2 and renal cell carcinoma.